Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.59M Buy
22,505
+754
+3% +$56.5K 0.09% 192
2025
Q4
$1.72M Buy
21,751
+1,472
+7% +$117K 0.07% 215
2025
Q3
$1.67M Buy
+20,279
New +$1.6M 0.07% 227
2025
Q2
Sell
-3,732
Closed -$300K 965
2025
Q1
$300K Buy
+3,732
New +$310K 0.02% 638
2024
Q4
Sell
-3,150
Closed -$260K 897
2024
Q3
$260K Sell
3,150
-708
-18% -$52.9K 0.12% 247
2024
Q2
$271K Buy
+3,858
New +$275K 0.13% 232
2023
Q4
Sell
-4,411
Closed -$278K 408
2023
Q3
$278K Buy
+4,411
New +$275K 0.15% 198
2022
Q2
Sell
-27,994
Closed -$1.97M 654
2022
Q1
$1.97M Buy
+27,994
New +$1.89M 0.19% 107
2017
Q3
Sell
-7,819
Closed -$383K 282
2017
Q2
$383K Buy
+7,819
New +$363K 0.12% 235

Other funds holding MET

StoneX Group's MET Position: Q1 2026 in Review

StoneX Group increased its MetLife (MET) stake by 3.5% in Q1 2026, buying an estimated $56.5K and bringing the position to 22,505 shares worth $1.59M. The position accounts for 0.09% of the portfolio, ranked #192.

StoneX Group first reported a position in MET in Q2 2017 and has held it in 9 quarters since. The position peaked at $1.97M in Q1 2022. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • StoneX Group held 22,505 shares of MetLife worth $1.59M as of Q1 2026.
  • StoneX Group bought 754 MetLife shares in Q1 2026, an estimated $56.5K.
  • MetLife made up 0.09% of StoneX Group's portfolio in Q1 2026, its #192 holding.
  • StoneX Group first reported a position in MetLife in Q2 2017 and has held it in 9 quarters since.
  • StoneX Group's MetLife position peaked at $1.97M in Q1 2022.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.